A RESPONSE TO: “COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES”

Detalles Bibliográficos
Autores principales: Kohli-Lynch, Ciaran N, Ruiz-Negrón, Natalia, Beal, Amy, Bellows, Brandon K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394429/
https://www.ncbi.nlm.nih.gov/pubmed/34337999
http://dx.doi.org/10.18553/jmcp.2021.27.8.1140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394429/
https://www.ncbi.nlm.nih.gov/pubmed/34337999
http://dx.doi.org/10.18553/jmcp.2021.27.8.1140

Ejemplares similares